W. King Engel

9.1k total citations · 1 hit paper
144 papers, 6.9k citations indexed

About

W. King Engel is a scholar working on Molecular Biology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, W. King Engel has authored 144 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 57 papers in Epidemiology and 40 papers in Cellular and Molecular Neuroscience. Recurrent topics in W. King Engel's work include Inflammatory Myopathies and Dermatomyositis (53 papers), Muscle Physiology and Disorders (44 papers) and Genetic Neurodegenerative Diseases (32 papers). W. King Engel is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (53 papers), Muscle Physiology and Disorders (44 papers) and Genetic Neurodegenerative Diseases (32 papers). W. King Engel collaborates with scholars based in United States, France and Ireland. W. King Engel's co-authors include Valerie Askanas, Renate B. Alvarez, Anna Nogalska, Janis McFerrin, John N. Whitaker, Marinos C. Dalakas, G. MILTON SHY, Jeffrey T. Somers, T Wanko and George Karpati and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

W. King Engel

144 papers receiving 6.4k citations

Hit Papers

NEMALINE MYOPATHY 1963 2026 1984 2005 1963 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NEMALINE MYOPATHY
    1963 346 citations W. King Engel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. King Engel United States 49 3.7k 2.5k 1.6k 1.3k 1.2k 144 6.9k
Valerie Askanas United States 47 4.0k 1.1× 3.2k 1.3× 1.8k 1.1× 915 0.7× 1.2k 1.0× 171 6.7k
B. Eymard France 53 4.4k 1.2× 1.0k 0.4× 2.3k 1.4× 2.6k 2.0× 776 0.7× 240 8.2k
Arthur P. Hays United States 61 3.9k 1.1× 886 0.4× 2.8k 1.7× 4.8k 3.8× 1.4k 1.2× 170 10.3k
Jerry R. Mendell United States 56 6.9k 1.9× 1.7k 0.7× 2.0k 1.3× 2.6k 2.1× 1.2k 1.0× 185 12.4k
Pascal Laforêt France 47 3.8k 1.0× 821 0.3× 1.4k 0.9× 1.1k 0.9× 2.0k 1.7× 270 7.4k
Kanneboyina Nagaraju United States 52 5.1k 1.4× 2.2k 0.9× 727 0.4× 359 0.3× 2.0k 1.7× 150 7.9k
Zarife Sahenk United States 49 4.6k 1.2× 492 0.2× 1.9k 1.1× 1.4k 1.1× 1.4k 1.2× 145 7.7k
Tetsumori Yamashima Japan 47 2.6k 0.7× 957 0.4× 1.4k 0.9× 1.3k 1.0× 867 0.7× 206 7.1k
Serenella Servidei Italy 51 6.8k 1.8× 491 0.2× 1.6k 1.0× 1.3k 1.0× 791 0.7× 224 9.4k
Cristina Mammucari Italy 33 6.5k 1.8× 2.1k 0.9× 1.1k 0.7× 563 0.4× 2.4k 2.0× 58 9.0k

Countries citing papers authored by W. King Engel

Since Specialization
Citations

This map shows the geographic impact of W. King Engel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. King Engel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. King Engel more than expected).

Fields of papers citing papers by W. King Engel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. King Engel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. King Engel. The network helps show where W. King Engel may publish in the future.

Co-authorship network of co-authors of W. King Engel

This figure shows the co-authorship network connecting the top 25 collaborators of W. King Engel. A scholar is included among the top collaborators of W. King Engel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. King Engel. W. King Engel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Engel, W. King. (2020). Classification of Neuromuscular Disorders. Elsevier eBooks. 7(2). 198–200. 1 indexed citations
2.
Nogalska, Anna, Carla D’Agostino, W. King Engel, & Valerie Askanas. (2012). Activation of the γ-secretase complex and presence of γ-secretase-activating protein may contribute to Aβ42 production in sporadic inclusion-body myositis muscle fibers. Neurobiology of Disease. 48(1). 141–149. 11 indexed citations
3.
Nogalska, Anna, Carla D’Agostino, W. King Engel, William L. Klein, & Valerie Askanas. (2010). Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers. Acta Neuropathologica. 120(5). 661–666. 38 indexed citations
4.
Nogalska, Anna, Carla D’Agostino, Chiara Terracciano, W. King Engel, & Valerie Askanas. (2010). Impaired Autophagy in Sporadic Inclusion-Body Myositis and in Endoplasmic Reticulum Stress-Provoked Cultured Human Muscle Fibers. American Journal Of Pathology. 177(3). 1377–1387. 84 indexed citations
5.
Nogalska, Anna, Chiara Terracciano, Carla D’Agostino, W. King Engel, & Valerie Askanas. (2009). p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Acta Neuropathologica. 118(3). 407–413. 116 indexed citations
6.
7.
Terracciano, Chiara, Anna Nogalska, W. King Engel, Sławomir Wójcik, & Valerie Askanas. (2007). G.O.2 In sporadic inclusion-body myositis (s-IBM) muscle fibers, Parkinson-disease-associated DJ-1 is oxidized and might play a novel pathogenic role. Neuromuscular Disorders. 17(9-10). 766–767. 1 indexed citations
8.
Askanas, Valerie & W. King Engel. (2002). Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms. Current Opinion in Neurology. 15(5). 525–531. 77 indexed citations
9.
Yang, Chih‐Chao, Renate B. Alvarez, W. King Engel, & Valerie Askanas. (1996). Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis. Neuroreport. 8(1). 153–158. 65 indexed citations
10.
Bilak, Masako M., Valerie Askanas, & W. King Engel. (1993). Strong immunoreactivity of ?1 co-localizes with ?-amyloid protein and ubiquitin in vacuolated muscle fibers of inclusion-body myositis. Acta Neuropathologica. 85(4). 378–382. 42 indexed citations
11.
Askanas, Valerie, et al.. (1993). β-amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. Neuroreport. 4(6). 815–818. 79 indexed citations
12.
Askanas, Valerie, W. King Engel, & Renate B. Alvarez. (1992). Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis.. PubMed. 141(1). 31–6. 118 indexed citations
13.
Kobayashi, Takayoshi, Valerie Askanas, & W. King Engel. (1990). <b>HIGH EXCITABILITY AND REMAINED SLOW CALCIUM REPOLARIZATION COMPONENTS OF ACTION POTENTIALS IN CULTURED HUMAN PARAMYOTONIA CONGENITA MUSCLE </b><b>CELLS </b>. Biomedical Research. 11(5). 299–305. 1 indexed citations
14.
Dalakas, Marinos C. & W. King Engel. (1983). Treatment of “permanent” muscle weakness in familial hypokalemic periodic paralysis. Muscle & Nerve. 6(3). 182–186. 35 indexed citations
15.
Avigan, Joel, Valerie Askanas, & W. King Engel. (1983). Muscle carnitine deficiency. Neurology. 33(8). 1021–1021. 17 indexed citations
16.
Whitaker, John N. & W. King Engel. (1974). A search for antibodies to neuronal nuclei in the serum of patients with myasthenia gravis. Neurology. 24(1). 61–61. 6 indexed citations
17.
Görden, Phillip, Robert C. Griggs, S. Peter Nissley, Jesse Roth, & W. King Engel. (1969). Studies of Plasma Insulin in Myotonic Dystrophy. The Journal of Clinical Endocrinology & Metabolism. 29(5). 684–690. 50 indexed citations
18.
Engel, W. King. (1966). Protein abnormalities in neuromuscular diseases. I. JAMA. 195(9). 754–760. 6 indexed citations
19.
Engel, W. King, et al.. (1963). Late-Onset Type of Skeletal-Muscle Phosphorylase Deficiency. New England Journal of Medicine. 268(3). 135–137. 76 indexed citations
20.
Engel, W. King, et al.. (1960). Myofibril formation in cultured skeletal muscle cells studied with antimyosin fluorescent antibody. Journal of Experimental Zoology. 144(3). 209–223. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerie Askanas Breakdown of academic impact, for papers by B. Eymard Breakdown of academic impact, for papers by Arthur P. Hays Breakdown of academic impact, for papers by Jerry R. Mendell Breakdown of academic impact, for papers by Pascal Laforêt Breakdown of academic impact, for papers by Kanneboyina Nagaraju Breakdown of academic impact, for papers by Zarife Sahenk Breakdown of academic impact, for papers by Tetsumori Yamashima Breakdown of academic impact, for papers by Serenella Servidei Breakdown of academic impact, for papers by Cristina Mammucari
Rankless by CCL
2026